Yılmaz, U. Et Al. 2011. Does the Hemabloker Have an Anti-angiogenesis Effect on Tumor Implanted Mice?. 3rd East Mediterranean ICLAS Symposium & XV. ICLAS General Assembly , (İstanbul, Turkey), 46-47.

Yılmaz, U., Çevik, A., Tekeli, F., Kalaycı, R., Zeybek, Ş. Ü., Kıran, B., ... Gökçe, M.(2011). Does the Hemabloker Have an Anti-angiogenesis Effect on Tumor Implanted Mice? . 3rd East Mediterranean ICLAS Symposium & XV. ICLAS General Assembly (pp.46-47). İstanbul, Turkey

Yılmaz, U Et Al. "Does the Hemabloker Have an Anti-angiogenesis Effect on Tumor Implanted Mice?," 3rd East Mediterranean ICLAS Symposium & XV. ICLAS General Assembly, İstanbul, Turkey, 2011

Yılmaz, U Et Al. "Does the Hemabloker Have an Anti-angiogenesis Effect on Tumor Implanted Mice?." 3rd East Mediterranean ICLAS Symposium & XV. ICLAS General Assembly , İstanbul, Turkey, pp.46-47, 2011

Yılmaz, U. Et Al. (2011) . "Does the Hemabloker Have an Anti-angiogenesis Effect on Tumor Implanted Mice?." 3rd East Mediterranean ICLAS Symposium & XV. ICLAS General Assembly , İstanbul, Turkey, pp.46-47.

@conferencepaper{conferencepaper, author={U Yılmaz Et Al. }, title={Does the Hemabloker Have an Anti-angiogenesis Effect on Tumor Implanted Mice?}, congress name={3rd East Mediterranean ICLAS Symposium & XV. ICLAS General Assembly}, city={İstanbul}, country={Turkey}, year={2011}, pages={46-47} }